NAG-1/GDF15 modulates hepcidin expression through STAT3 and SMAD pathways
Archives of Biochemistry and Biophysics · 2026
DOI: 10.1016/j.abb.2025.110724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026. Verfasst von Pattawika Lertpatipanpong und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea; Department of Pha…. Hauptthemen laut MEDLINE: Hepcidins, Growth Differentiation Factor 15, STAT3 Transcription Factor, Smad Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, National Research Foundation of Korea, Seoul National University.
Abstract (Originalsprache)
Hepcidin, a liver-derived hormone, is a central regulator of iron homeostasis and a key contributor to anemia of inflammation (AI). This study investigates the regulatory role of NAG-1 (Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1; also known as GDF15) in modulating hepcidin expression. In NAG-1 transgenic mice, elevated circulating NAG-1 was associated with markedly reduced hepatic hepcidin expression, demonstrating an in vivo role for NAG-1 in hepcidin suppression. To further dissect the mechanism, we established HepG2 cell lines stably overexpressing either NAG-1 WT (wild type), which produces both pro- and mature forms, or the R193A mutant, which secretes only the pro-form. Both WT and R193A significantly suppressed IL-6- and BMP6-induced hepcidin expression, with the mutant showing slightly stronger inhibition in some assays. Mechanistically, NAG-1 inhibited both the JAK/STAT3 and BMP6/SMAD pathways by reducing STAT3 activation and Smad1/5/9 phosphorylation, thereby limiting their recruitment to the HAMP promoter. Furthermore, co-expression of NAG-1 with the transcriptional corepressor SMILE produced an additive suppression of hepcidin, through enhanced inhibition of STAT3 signaling, despite only weak physical interaction between the two proteins. Together, these findings establish NAG-1 as a negative regulator of hepcidin transcription and demonstrate that the pro-form retains substantial biological activity within cells, providing new therapeutic insights into the management of anemia of inflammation through modulation of iron metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea; Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan Universit…
- Department of Biopharmacy, Faculty of Pharmacy, Srinakharinwirot University, Ongkharak, Nakhon Nayok, 26120, Thailand.
- College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea.
- Department of Internal medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, 07062, South Korea. Electronic address: jyj0601@snu.ac.kr.
- College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea. Electronic address: baeksj@snu.ac.kr.
Förderung
- Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University
- National Research Foundation of Korea
- Seoul National University
- Seoul Metropolitan Government Seoul National University Boramae Medical Center
Zitieren
APA
Lertpatipanpong, P., Krisanapun, C., Boonruang, K., Jung, Y. J., & Baek, S. J. (2026). NAG-1/GDF15 modulates hepcidin expression through STAT3 and SMAD pathways. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110724
Vancouver
Lertpatipanpong P, Krisanapun C, Boonruang K, Jung YJ, Baek SJ. NAG-1/GDF15 modulates hepcidin expression through STAT3 and SMAD pathways. Archives of Biochemistry and Biophysics. 2026. doi:10.1016/j.abb.2025.110724
BibTeX
@article{Lertpatipanpong2026,
author = {Lertpatipanpong, Pattawika and Krisanapun, Chutwadee and Boonruang, Kanokkan and Jung, Yong Jin and Baek, Seung Joon},
title = {NAG-1/GDF15 modulates hepcidin expression through STAT3 and SMAD pathways},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
doi = {10.1016/j.abb.2025.110724}
}
EUVIMED